Myoferlin is expressed in normal lung parenchyma and normal bronchial epithelium.63 A recent study found that myoferlin localizes to the cytoplasm of the cells in all NSCLC pathological subtypes, and adenocarcinomas exhibited the largest proportion.42 Moreover, in adenocarcinoma cases, myoferlin‐positive tumours may indicate a poor prognosis (odds ratio = 2.94; P = .339), while myoferlin and VEGFR‐2 expression exhibited a significant correlation in squamous cell carcinoma (P = .001), especially in stage I patients.42 This evidence concerns the gene MYOF and non-small cell lung carcinoma.